Metformin: a new oral biguanide

1996, 1 DeFronzo, 1991, Insulin resistance: A multifaceted syndrome responsible for NIDDM obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease, Diabetes Care, 14, 173, 10.2337/diacare.14.3.173 DeFronzo, 1991, Mechanism of metformin action in obese and lean non-insulin-dependent diabetic subjects, J Clin Endocrinol Metab, 73, 1294, 10.1210/jcem-73-6-1294 DeFronzo, 1995, Efficacy of metformin in patients with non-insulin dependent diabetes mellitus, NEJM, 333, 541, 10.1056/NEJM199508313330902 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, NEJM, 329, 977, 10.1056/NEJM199309303291401 1995, Consensus statement on pharmacologic therapy for patients with non—insulin-dependent diabetes mellitus, Diabetes Care, 18, 1510 1994, 1 Stumvoll, 1995, Metabolic effects of metformin in non-insulin-dependent diabetes mellitus, NEJM, 333, 550, 10.1056/NEJM199508313330903 Johnson, 1992, The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients, Metabolism, 42, 1217, 10.1016/0026-0495(93)90284-U Crofford, 1995, Metformin, NEJM, 333, 588, 10.1056/NEJM199508313330910 Campbell, 1985, Metformin and the sulphonylureas: The comparative risk, Horm Metab Res, 105 Trischitta, 1992, Comparison of combined therapies in treatment of secondary failure to glyburide, Diabetes Care, 15, 539, 10.2337/diacare.15.4.539 Rossetti, 1990, Effect of metformin treatment on insulin action in diabetic rats: In vivo and in vitro correlations, Metabolism, 39, 425, 10.1016/0026-0495(90)90259-F Bailey, 1992, Biguanides and NIDDM, Diabetes Care, 15, 755, 10.2337/diacare.15.6.755 1993, 506 Klip, 1990, Cellular mechanism of action of metformin, Diabetes Care, 13, 696, 10.2337/diacare.13.6.696 Laulau, 1989, Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: A study of metformin elimination, Int J Clin Pharmacol Ther Toxicol, 27, 285 Dorman, 1991, Double-blind evaluation of efficacy and tolerability to metformin in NIDDM, Diabetes Care, 14, 342, 10.2337/diacare.14.4.342 Goodman, 1993, Efficacy and safety of metformin in NIDDM: Results of a multicenter trial, Diabetes, 42, 178 Josephkutty, 1990, Comparison of tolbutamide and metformin in elderly diabetic patients, Diabetic Med, 7, 510, 10.1111/j.1464-5491.1990.tb01433.x Hermann, 1991, Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles, Eur J Clin Pharmacol, 41, 263, 10.1007/BF00315441 Rains, 1989, The reduction of low density lipoprotein cholesterol by metformin is maintained with long-term therapy, J R Soc Med, 82, 93, 10.1177/014107688908200213 Montanari, 1992, Treatment with low dose metformin in patients with peripheral vascular disease, Pharm Res, 25, 63, 10.1016/S1043-6618(05)80065-9 Giugliano, 1993, Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women, Diabetes Care, 16, 1387, 10.2337/diacare.16.10.1387 Giugliano, 1993, Metformin for obese, insulin-treated diabetic patients: Improvement in glycaemic control and reduction of metabolic risk factors, Eur J Clin Pharmacol, 44, 107, 10.1007/BF00315466 Reaven, 1992, Combined metformin-sulfonylurea treatment of patients with non-insulin-dependent diabetes in fair to poor glycemic control, J Clin Endocrinol Metab, 74, 1020, 10.1210/jc.74.5.1020 Klein, 1991, Sulfonylurea-metformin-combination vs. sulfonylurea-insulin-combination in secondary failures of sulfonylurea monotherapy: Results of a prospective randomized study in 50 patients, Diabete Metabol, 17, 235 DeFronzo, 1993, Combined metformin/glyburide treatment in NIDDM patients not optimally responding to maximum dose sulfonylurea: Results of a multicenter trial, Diabetes, 42, 455 Hermann, 1994, Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations, Diabetes Care, 17, 1100, 10.2337/diacare.17.10.1100 Bailey, 1988, Metformin revisited: Its action and indications for use, Diabetic Med, 5, 315, 10.1111/j.1464-5491.1988.tb00996.x Marchetti, 1991, Pharmacokinetic optimisation of oral hypoglycemic therapy, Clin Pharmacokinet, 21, 308, 10.2165/00003088-199121040-00006 Gan, 1992, Biguanide-associated lactic acidosis: Case report and review of the literature, Arch Intern Med, 152, 2333, 10.1001/archinte.152.11.2333 Glucophage package insert. Princeton: Bristol-Myers Squibb Co; Pharmaceutical Division; 1995. Somogyi, 1987, Reduction of metformin renal tubular secretion by cimetidine, Br J Clin Pharmacol, 23, 545, 10.1111/j.1365-2125.1987.tb03090.x 1994, 83 Melchior, 1996, Metformin: An antihyperglycemic agent for treatment of type II diabetes, Ann Pharmacother, 30, 158, 10.1177/106002809603000210 Karlsson, 1995, Metformin comes to America: What to do now, Clin Diabetes, 13, 78